Ashish Dhawan’s portfolio features 11 stocks with a net worth exceeding ₹3,296.8 crore. Focused on sectors like pharmaceuticals, financials and consumer goods, his investments include Glenmark Pharma, M&M Financial and Arvind Fashions, showcasing a diversified approach to long-term value creation.
Table of Contents
Introduction To Portfolio Of Ashish Dhawan
Mahindra and Mahindra Ltd
Founded in 1945, Mahindra and Mahindra Limited has grown into one of India’s largest automotive manufacturers under the leadership of Anand Mahindra. The company has diversified into multiple sectors including farm equipment, automotive, financial services and IT. Known for its robust SUVs and tractors, M&M has established a strong presence across the aerospace, agribusiness and clean energy sectors.
• Market Cap: ₹3,36,494.87 Cr
• Current Share Price: ₹2,807.2
• Returns: 1Y (81.80%), 1M (-11.66%), 6M (21.93%)
• 5Y Average Net Profit Margin: 5.11%
• Dividend Yield: 0.045%
• 5Y CAGR: 37.15%
• Sector: Four Wheelers
Glenmark Pharmaceuticals Ltd
Established in 1977 by Gracias Saldanha, Glenmark Pharmaceuticals is a global pharmaceutical company focusing on dermatology, respiratory and oncology treatments. Under Glenn Saldanha’s leadership, the company has expanded its presence globally with innovative products like Ryaltris and maintains a strong research focus in these therapeutic areas.
• Market Cap: ₹43,279.20 Cr
• Current Share Price: ₹1,533.7
• Returns: 1Y (104.21%), 1M (-15.92%), 6M (53.00%)
• 5Y Average Net Profit Margin: 2.88%
• Dividend Yield: 2.41%
• 5Y CAGR: 40.31%
• Sector: Pharmaceuticals
Quess Corp Ltd
Founded in 2007, Quess Corp is India’s leading business services provider, helmed by Chairman Ajit Isaac. The company specializes in workforce management, operating asset management and global technology solutions. With operations across India and international markets, Quess Corp serves various sectors through comprehensive staffing and business support services.
• Market Cap: ₹9,469.69 Cr
• Current Share Price: ₹637.15
• Returns: 1Y (27.39%), 1M (-11.51%), 6M (-0.01%)
• 5Y Average Net Profit Margin: 0.20%
• Dividend Yield: 1.57%
• 5Y CAGR: 2.34%
• Sector: Employment Services
Religare Enterprises Ltd
Religare Enterprises, established in 2000, is a diversified financial services group offering broking, lending and insurance services. The company has evolved into a significant player in India’s financial sector, with multiple subsidiaries covering various aspects of financial services including capital markets and insurance.
• Market Cap: ₹8,100.16 Cr
• Current Share Price: ₹245.24
• Returns: 1Y (15.46%), 1M (-10.63%), 6M (11.65%)
• 5Y Average Net Profit Margin: -12.68%
• Dividend Yield: 0%
• 5Y CAGR: 35.90%
• Sector: Investment Banking & Brokerage
Arvind Fashions Ltd
Arvind Fashions, a part of the Lalbhai Group, is a leading branded apparel and accessories company in India. The company manages a portfolio of international brands including US Polo, Arrow and Tommy Hilfiger. With over 1,300 standalone stores across 192 cities, it has established itself as a significant player in Indian fashion retail.
• Market Cap: ₹7,395.22 Cr
• Current Share Price: ₹555
• Returns: 1Y (43.23%), 1M (-11.81%), 6M (19.62%)
• 5Y Average Net Profit Margin: -8.78%
• Dividend Yield: 0.22%
• 5Y CAGR: 8.05%
• Sector: Textiles
Equitas Small Finance Bank Ltd
Established in 2016, Equitas Small Finance Bank focuses on providing banking services to underserved segments. The bank, under the leadership of P.N. Vasudevan, specializes in microfinance, commercial vehicle finance and small business loans. It has transformed from a microfinance institution to a full-service bank serving retail and MSE sectors.
• Market Cap: ₹7,134.09 Cr
• Current Share Price: ₹62.63
• Returns: 1Y (-36.09%), 1M (-16.48%), 6M (-33.44%)
• 5Y Average Net Profit Margin: 10.11%
• Dividend Yield: 1.59%
• 5Y CAGR: 0%
• Sector: Private Banks
Greenlam Industries Ltd
Greenlam Industries, founded in 2013, is India’s largest laminate manufacturer. Under the leadership of Saurabh Mittal, the company has become a global leader in decorative surfaces, producing laminates, veneers and engineered wooden flooring through its factories in Behror and Nalagarh.
• Market Cap: ₹6,598.12 Cr
• Current Share Price: ₹517.2
• Returns: 1Y (-6.99%), 1M (1.49%), 6M (-12.03%)
• 5Y Average Net Profit Margin: 6.04%
• Dividend Yield: 0.32%
• 5Y CAGR: 21.73%
• Sector: Building Products – Laminates
Dish TV India Ltd
Dish TV India, established in 2003, is one of India’s pioneering direct-to-home (DTH) television service providers. The company, part of the Essel Group, offers multiple brands including Dish TV, Zing and d2h, serving millions of subscribers with over 700 channels and innovative smart TV solutions.
• Market Cap: ₹2,078.78 Cr
• Current Share Price: ₹11.29
• Returns: 1Y (-36.03%), 1M (-20.32%), 6M (-31.78%)
• 5Y Average Net Profit Margin: -64.99%
• Dividend Yield: 0%
• 5Y CAGR: -3.37%
• Sector: Cable & D2H
AGI Greenpac Ltd
Established in 1981 through the acquisition of The Associated Glass Industries Limited, AGI Greenpac has evolved into one of India’s leading glass container manufacturers. The company expanded into PET bottles in 2011 and security caps in 2018. With state-of-the-art manufacturing facilities, they provide innovative packaging solutions across industries.
• Market Cap: ₹5,972.54 Cr
• Current Share Price: ₹923.15
• Returns: 1Y (-5.21%), 1M (-8.52%), 6M (31.95%)
• 5Y Average Net Profit Margin: 8.66%
• Dividend Yield: 0.65%
• 5Y CAGR: 80.49%
• Sector: Packaging
RPSG Ventures Ltd
RPSG Ventures Limited is a diversified company operating in IT, business process outsourcing, property development, FMCG and sports activities. The company has expanded into the ayurvedic industry through its subsidiary Herbolab India Private Limited, marketing products under Dr. Vaidya’s brand and maintains real estate operations through Quest Properties India Limited.
• Market Cap: ₹3,190.03 Cr
• Current Share Price: ₹964.15
• Returns: 1Y (67.97%), 1M (-10.30%), 6M (42.78%)
• 5Y Average Net Profit Margin: -0.77%
• Dividend Yield: 0%
• 5Y CAGR: 25.74%
• Sector: Packaged Foods & Meats
Who Is Ashish Dhawan?
Ashish Dhawan is a renowned Indian investor and philanthropist, known for his expertise in private equity and portfolio diversification. Founder of ChrysCapital, he has a successful track record in the Indian stock market, focusing on sectors with high growth potential.
He is also the founder of Central Square Foundation, promoting education reform in India. Dhawan’s disciplined investment approach balances value and growth strategies, making him a respected figure among market analysts and investors. His insights on midcap and smallcap stocks are particularly admired for their strategic depth.
His philanthropic initiatives reflect his commitment to societal development. By combining financial expertise and social responsibility, Dhawan has inspired many in the investment community and beyond, showcasing a holistic approach to wealth creation.
Features Of Ashish Dhawan Portfolio Stocks
The main features include a strategic focus on education technology and digital transformation sectors, emphasizing companies with proven business models, strong management teams and significant market opportunities. The portfolio demonstrates high growth potential and robust governance.
- Strategic Vision: The portfolio reflects a deep understanding of growth sectors, particularly in education and technology. Investments showcase expertise in identifying companies with transformative potential and strong market positioning.
- Market Leadership: Selected companies maintain dominant positions through innovative solutions and strong execution capabilities. The focus remains on businesses showing potential for sustained market leadership.
- Growth Focus: Companies demonstrate consistent revenue expansion and profitability improvements. Emphasis stays on businesses with strong balance sheets and efficient capital allocation strategies.
Ashish Dhawan Stocks List Based on 6-Month Return
The table below shows the Ashish Dhawan Stocks List Based on 6 Month Return
| Name | Close Price (rs) | 6M Return |
| Glenmark Pharmaceuticals Ltd | 1533.70 | 53.00 |
| RPSG Ventures ltd | 964.15 | 42.78 |
| AGI Greenpac ltd | 923.15 | 31.95 |
| Mahindra and Mahindra Ltd | 2807.20 | 21.93 |
| Arvind Fashions ltd | 555.00 | 19.62 |
| Religare Enterprises ltd | 245.24 | 11.65 |
| Quess Corp ltd | 637.15 | -0.01 |
| Greenlam Industries ltd | 517.20 | -12.03 |
| Dish TV India Ltd | 11.29 | -31.78 |
| Equitas Small Finance Bank Ltd | 62.63 | -33.44 |
Best Ashish Dhawan Multibagger Stocks Based on 5-Year Net Profit Margin
The table below shows the Best Ashish Dhawan Multibagger Stocks Based on 5 Year Net Profit Margin
| Name | 5Y Avg Net Profit Margin % | Close Price (rs) |
| Equitas Small Finance Bank Ltd | 10.11 | 62.63 |
| AGI Greenpac ltd | 8.66 | 923.15 |
| Greenlam Industries ltd | 6.04 | 517.20 |
| Mahindra and Mahindra Ltd | 5.11 | 2807.20 |
| Glenmark Pharmaceuticals Ltd | 2.88 | 1533.70 |
| Quess Corp ltd | 0.20 | 637.15 |
| RPSG Ventures ltd | -0.77 | 964.15 |
| Arvind Fashions ltd | -8.78 | 555.00 |
| Religare Enterprises ltd | -12.68 | 245.24 |
| Dish TV India Ltd | -64.99 | 11.29 |
Top Stocks Held By Ashish Dhawan Based on 1M Return
The table below shows the Top Stocks Held By Ashish Dhawan Based on a 1M Return
| Name | Close Price (rs) | 1M Return (%) |
| Greenlam Industries ltd | 517.20 | 1.49 |
| AGI Greenpac ltd | 923.15 | -8.52 |
| RPSG Ventures ltd | 964.15 | -10.30 |
| Religare Enterprises ltd | 245.24 | -10.63 |
| Quess Corp ltd | 637.15 | -11.51 |
| Mahindra and Mahindra Ltd | 2807.20 | -11.66 |
| Arvind Fashions ltd | 555.00 | -11.81 |
| Glenmark Pharmaceuticals Ltd | 1533.70 | -15.92 |
| Equitas Small Finance Bank Ltd | 62.63 | -16.48 |
| Dish TV India Ltd | 11.29 | -20.32 |
Sectors Dominating Ashish Dhawan’s Portfolio
Ashish Dhawan’s portfolio emphasizes sectors like pharmaceuticals, financial services and consumer goods. Glenmark Pharma, M&M Financial and Greenlam Industries are examples of his well-diversified investments, reflecting his focus on long-term value creation across critical industries.
The pharmaceutical sector leads his portfolio with Glenmark Pharma contributing significant value. Financial services, including holdings like M&M Financial, demonstrate his belief in India’s evolving banking and finance landscape. Consumer goods and allied sectors further diversify his investments, balancing risk and returns.
Dhawan’s strategic diversification ensures resilience against market fluctuations. His sectoral choices align with economic growth drivers, highlighting his expertise in identifying opportunities in promising industries with consistent potential for expansion.
Midcap and Smallcap Focus in Ashish Dhawan’s Portfolio
Ashish Dhawan’s portfolio predominantly features midcap and smallcap stocks, demonstrating his strategic focus on high-growth potential investments. Stocks like Greenlam Industries and Quess Corp showcase his confidence in emerging companies with strong fundamentals and scalability.
Midcap stocks offer a balance of risk and growth, evident in his stake in AGI Greenpac. Smallcap investments, such as Palred Technologies, reflect his ability to identify niche opportunities in developing industries. This focus enhances his portfolio’s growth trajectory while maintaining diversification.
By prioritizing midcap and smallcap stocks, Dhawan taps into India’s economic growth story. These stocks often outperform during favourable market conditions, showcasing his adept understanding of market dynamics and strategic positioning.
High Dividend Yield Ashish Dhawan Stocks List
The table below shows the High Dividend Yield Ashish Dhawan Stocks List
| Name | Close Price (rs) | Dividend Yield |
| Glenmark Pharmaceuticals Ltd | 1533.70 | 2.41 |
| Equitas Small Finance Bank Ltd | 62.63 | 1.59 |
| Quess Corp ltd | 637.15 | 1.57 |
| AGI Greenpac ltd | 923.15 | 0.65 |
| Greenlam Industries ltd | 517.20 | 0.32 |
| Arvind Fashions ltd | 555.00 | 0.22 |
| Mahindra and Mahindra Ltd | 2807.20 | 0.05 |
Ashish Dhawan’s Net Worth
Ashish Dhawan’s portfolio holds a net worth exceeding ₹3,296.8 crore, reflecting his astute investment strategies. His holdings across various sectors ensure steady growth, despite market fluctuations, positioning him as a top investor in India.
The net worth declined by -25.6% in the latest quarter due to market corrections. However, his investments in robust sectors like pharmaceuticals and financials indicate resilience. Key stocks like Glenmark Pharma and M&M Financial anchor his portfolio’s value.
Dhawan’s wealth reflects his disciplined approach to investing and portfolio management. By focusing on diversified sectors, he sustains long-term growth while navigating short-term volatility effectively.
Historical Performance of Ashish Dhawan Portfolio Stocks
Ashish Dhawan’s portfolio has showcased consistent growth over the years, driven by diversified investments in high-growth sectors. Stocks like Glenmark Pharma and Arvind Fashions have delivered notable returns, enhancing his overall portfolio performance.
The historical data reveals resilience during market downturns. Dhawan’s focus on midcap and smallcap stocks like AGI Greenpac highlights his ability to identify under-the-radar opportunities. His strategic diversification mitigates risks while optimizing returns.
This performance underscores Dhawan’s investment expertise and market foresight. His portfolio reflects a balance of stability and growth, appealing to investors seeking consistent long-term returns in dynamic market conditions.
Ideal Investor Profile for Ashish Dhawan’s Portfolio
Investors seeking diversified exposure to midcap and smallcap stocks with high growth potential may find Ashish Dhawan’s portfolio appealing. His focus on pharmaceuticals, financials and consumer goods aligns with long-term wealth-building goals.
This portfolio suits investors with moderate to high-risk tolerance, given the inclusion of smallcap stocks like Palred Technologies. Individuals aiming for sectoral diversification and exposure to India’s growth sectors can benefit from his strategic approach.
By leveraging Dhawan’s investment strategies, investors can access promising sectors with consistent potential. This portfolio is ideal for those prioritizing growth and diversification in their financial planning.
Factors To Consider When Investing In Ashish Dhawan Portfolio Stocks
Investing in Ashish Dhawan’s portfolio requires consideration of market dynamics, sectoral trends and stock fundamentals. His focus on midcap and smallcap stocks emphasizes growth potential but entails higher risk.
Evaluate the financial performance of companies like Glenmark Pharma and M&M Financial for informed decision-making. Monitor economic conditions affecting key sectors like pharmaceuticals and consumer goods, which dominate his holdings.
Diversification within the portfolio mitigates risks, making it essential to align investments with personal financial goals. Balancing growth opportunities and potential volatility ensures strategic advantages when investing in Dhawan’s stocks.
How To Invest In Ashish Dhawan Portfolio?
Investing in Ashish Dhawan’s portfolio involves selecting publicly traded stocks he holds, such as Glenmark Pharma and AGI Greenpac. Open a trading account with Alice Blue to access these stocks conveniently.
Research stock performance, sector trends and market conditions to align investments with Dhawan’s strategy. Focus on midcap and smallcap stocks for growth potential, ensuring diversification and long-term value creation in your portfolio.
Advantages Of Investing In Ashish Dhawan Portfolio Stocks
The main advantages include exposure to high-growth sectors with a strong emphasis on technology and education, backed by companies demonstrating robust market leadership and scalable business models. The portfolio offers opportunities in transformative businesses.
- Market Position: Selected companies maintain dominant positions through innovative solutions and strong execution. The portfolio demonstrates a preference for businesses with established market presence and growth potential.
- Innovation Edge: Companies showcase commitment to technological advancement and market disruption. Investments target organizations driving significant changes through innovative solutions and digital transformation.
- Growth Focus: The portfolio reflects consistent revenue expansion and profitability improvements. Selected businesses demonstrate strong unit economics and clear paths to sustainable market leadership.
Risks Of Investing In Ashish Dhawan Portfolio Stocks
The main risks involve market volatility in high-growth sectors, regulatory changes and concentration in specific segments. Investors must consider these factors carefully while evaluating potential returns based on individual risk tolerance.
- Market Risk: High-growth stocks experience significant price fluctuations in response to market conditions. Broader market sentiments affect valuations substantially during economic cycles.
- Regulatory Impact: The education technology sector faces evolving compliance requirements. Success depends on companies’ ability to adapt while maintaining growth trajectories.
Ashish Dhawan Portfolio Stocks GDP Contribution
Stocks in Ashish Dhawan’s portfolio significantly contribute to India’s GDP through sectors like pharmaceuticals and financial services. Companies like Glenmark Pharma drive healthcare advancements, while M&M Financial supports banking and economic inclusion.
This contribution highlights Dhawan’s investment alignment with India’s economic growth. His portfolio reflects strategic exposure to key growth drivers, emphasizing resilience and scalability in dynamic markets.
Who Should Invest in Ashish Dhawan Portfolio Stocks?
Investors with a medium- to high-risk appetite seeking exposure to midcap and smallcap stocks should consider Ashish Dhawan’s portfolio. Its focus on pharmaceuticals, financials and emerging sectors caters to long-term wealth-building goals.
This portfolio is ideal for those aiming to diversify investments while leveraging growth opportunities. Dhawan’s strategic approach ensures a balance of risk and reward, appealing to growth-focused investors seeking steady returns over time.
Ashish Dhawan Multibagger Stocks – FAQs
As per the latest corporate shareholdings filed, Ashish Dhawan publicly holds a portfolio of 42 stocks with a net worth exceeding Rs. 3,129.0 crore. His investments span across sectors with significant holdings in education and technology companies.
Top Ashish Dhawan Portfolio Stocks #1: Mahindra and Mahindra Ltd
Top Ashish Dhawan Portfolio Stocks #2: Glenmark Pharmaceuticals Ltd
Top Ashish Dhawan Portfolio Stocks #3: Quess Corp Ltd
Top Ashish Dhawan Portfolio Stocks #4: Religare Enterprises Ltd
Top Ashish Dhawan Portfolio Stocks #5: Arvind Fashions Ltd
Top 5 Ashish Dhawan Portfolio Stocks based on market capitalization.
The main best Ashish Dhawan stocks based on one-year returns include Glenmark Pharmaceuticals Ltd, Mahindra and Mahindra Ltd, RPSG Ventures Ltd, Arvind Fashions Ltd and Quess Corp Ltd, showcasing robust growth, market resilience and strong fundamentals across diverse sectors.
The top 5 multi-bagger stocks picked by Ashish Dhawan include Glenmark Pharma, AGI Greenpac, Greenlam Industries, Quess Corp and Palred Technologies. These stocks exhibit strong growth potential, robust fundamentals and scalability, aligning with Dhawan’s strategic focus on high-growth midcap and smallcap investments.
Ashish Dhawan’s top gainers this year include Glenmark Pharma and AGI Greenpac, showing steady growth due to strong fundamentals. However, Arvind Fashions emerged as a significant loser, with a reduced stake and market fluctuations impacting its performance negatively.
Yes, investments can be safe with proper research and risk management. Focus on established companies like Glenmark Pharma and M&M Financial while maintaining a disciplined investment approach and diversification strategy.
Start by opening a demat account with Alice Blue and conducting a comprehensive research. Focus on understanding company fundamentals, growth potential and market dynamics while maintaining a disciplined investment approach.
Yes, investment opportunities exist in well-established companies with proven track records. The portfolio includes market leaders across healthcare and financial services sectors showing a focus on sustainable growth potential.
We hope you’re clear on the topic, but there’s more to explore in stocks, commodities, mutual funds, and related areas. Here are important topics to learn about.
Disclaimer: The above article is written for educational purposes and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
